Filings
Finds words inside filing documents. Searching Liminatus Pharma, Inc.'s filings · 44 documents indexed.
13 documents · 42 matches
-
LIMN Liminatus Pharma, Inc. 10-K 2026-03-31
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operation.
going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) ASC 205-40, Presentation of Financial Statements—Going Concern6 matches in this document -
LIMN Liminatus Pharma, Inc. 10-Q 2026-08-14
Item 1 · Note 1. Description of Organization and Business Operations
going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) ASC 205-40, Presentation of Financial Statements—Going Concern4 matches in this document -
LIMN Liminatus Pharma, Inc. 10-Q 2026-05-15
Item 1 · Note 1. Description of Organization and Business Operations
going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) ASC 205-40, Presentation of Financial Statements—Going Concern4 matches in this document -
LIMN Liminatus Pharma, Inc. 10-Q 2025-11-14
Item 1 · Note 1. Description of Organization and Business Operations
going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) ASC 205-40, Presentation of Financial Statements—Going Concern4 matches in this document -
LIMN Liminatus Pharma, Inc. 10-Q 2025-10-06
Item 1 · Note 1. Description of Organization and Business Operations
going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) ASC 205-40, Presentation of Financial Statements—Going Concern4 matches in this document -
LIMN Liminatus Pharma, Inc. 8-K/A 2025-06-02
Note 1. Organization and Description of Business Operations
going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) ASC 205-40, Presentation of Financial Statements—Going Concern3 matches in this document -
LIMN Liminatus Pharma, Inc. 8-K/A 2025-06-02
going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) ASC 205-40, Presentation of Financial Statements—Going Concern2 matches in this document -
LIMN Liminatus Pharma, Inc. 10-Q 2025-06-02
Item 1 · Note 1. Description of Organization and Business Operations
going concern twelve months from the issuance date of these unaudited condensed consolidated financial statements. As such, this raises substantial2 matches in this document -
LIMN Liminatus Pharma, Inc. 8-K/A 2025-06-02
Item 2.01. Completion of Acquisition or Disposition of Assets.
going concern within one year after the date that the accompanying financial statements are issued. The Company’s financial statements4 matches in this document -
LIMN Liminatus Pharma, Inc. 8-K/A 2025-06-02
Note 1. Organization and Description of Business Operations
going concern within one year after the date that the accompanying unaudited condensed financial statements are issued. The Company’s financial3 matches in this document -
LIMN Liminatus Pharma, Inc. 8-K/A 2025-06-02
going concern within one year after the date that the accompanying unaudited condensed financial statements are issued. The Company’s financial4 matches in this document -
LIMN Liminatus Pharma, Inc. 8-K 2026-07-06
Item 9.01. Financial Statements and Exhibits.
going concern; performance of the Company’s and InnocsAI’s business; failure to realize the anticipated benefits of the proposed1 match in this document -
LIMN Liminatus Pharma, Inc. 8-K 2026-06-03
going concern; performance of the Company’s business; risks relating to the Company’s sources of cash and cash resources1 match in this document
Page 1 of 1 · 13 documents